1. Home
  2. WOR vs SYRE Comparison

WOR vs SYRE Comparison

Compare WOR & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Enterprises Inc.

WOR

Worthington Enterprises Inc.

HOLD

Current Price

$52.32

Market Cap

2.6B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$47.33

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOR
SYRE
Founded
1955
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
WOR
SYRE
Price
$52.32
$47.33
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$59.67
$60.13
AVG Volume (30 Days)
226.3K
684.0K
Earning Date
03-24-2026
05-07-2026
Dividend Yield
1.46%
N/A
EPS Growth
N/A
N/A
EPS
1.25
N/A
Revenue
$1,153,762,000.00
N/A
Revenue This Year
$18.05
N/A
Revenue Next Year
$5.29
N/A
P/E Ratio
$41.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$43.35
$10.91
52 Week High
$70.91
$51.06

Technical Indicators

Market Signals
Indicator
WOR
SYRE
Relative Strength Index (RSI) 52.62 60.82
Support Level $51.36 $39.64
Resistance Level $57.97 N/A
Average True Range (ATR) 2.01 2.58
MACD 0.61 0.36
Stochastic Oscillator 83.00 66.31

Price Performance

Historical Comparison
WOR
SYRE

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: